Committee on Radiopharmaceuticals

Committee Charges

  • Receiving direction from and coordinating with the Board of Directors of the Society of Nuclear Medicine and Molecular Imaging, the Committee on Radiopharmaceuticals will:
    • Provide advice and data on isotope availability, including potential shortages of medically important radionuclides and enriched targets
    • Facilitate interactions with appropriate Federal agencies, legislative bodies, and other organizations to advocate for the availability of radionuclides essential to medicine and research
    • Provide advice and data on policies relevant to radiopharmaceutical availability and appropriate utilization
    • Provide timely information to the SNMMI membership regarding radionuclide and radiopharmaceutical availability and appropriate utilization
    • Provide advice on other issues related to radionuclides and radiopharmaceuticals as necessary. 

BUDs for Tc 99m Radiopharmaceuticals

Committee Members

  • Stephen C. Dragotakes, BS, RPh, BCNP, FAPhA (Committee Chairperson)
  • Cathy Sue Cutler, PhD, FSNMMI (Board Liaison)
  • Carolyn J. Anderson, PhD, FSNMMI (Committee Member)
  • Marc S. Berridge, PhD (Committee Member)
  • Corrine Bienat (Committee Member)
  • Roy W. Brown, BS, MBA (Committee Member)
  • Hancheng Cai, PhD (Committee Member)
  • David W. Dick, PhD (Committee Member)
  • Constantinous Economou (Committee Member)
  • Patricia E. Edem, PhD (Committee Member)
  • Fred P. Gattas, III, PharmD, BCNP (Committee Member)
  • Munir Ghesani, MD, FACNM, FSNMMI (Committee Member)
  • Richard L. Green, R.Ph., BCNP, FAPhA (Committee Member)
  • Scott P. Knishka, BCNP (Committee Member)
  • Suzanne E. Lapi, PhD, FSNMMI (Committee Member)
  • Steven H. Liang, PhD (Committee Member)
  • Molly E. Martin, PhD, PharmD, BCNP (Committee Member)
  • Steve Mattmuller, MS, RPh, BCNP (Committee Member)
  • Michael Nickels, PhD (Committee Member)
  • Mukesh Pandey, PhD (Committee Member)
  • Michele A. Panichi-Egberts, CNMT,RT(N),FSNMMI-TS (Committee Member)
  • Vanessa A. Sanders, PhD (Committee Member)
  • Svetlana V. Selivanova, PhD (Committee Member)
  • Mark A. Sellmyer, MD, PhD (Committee Member)
  • Mark R. Soffing, PharmD, MBA, BCNP (Committee Member)
  • Kara Weatherman, PharmD (Committee Member)
  • David V. Wilson, BS, RPh, BCNP (Committee Member)
  • Steven Zigler, PhD (Committee Member)
  • Christina M. Arenas, JD, MPH (Liaison)